Light, melatonin and internal cancers - Recent facts and research perspectives;Licht, melatonin und innere krebserkrankungen - Aktuelle fakten und forschungsperspektiven

Gesundheitswesen

Volumn 64, Issue 5, 2002, Pages 278-283

  Erren, Thomas C ^a   Stevens, R G ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cancer; Dosimetry; Light; Melatonin; Ubiquitous exposure

Indexed keywords

HORMONE; MELATONIN;

ARCTIC; ARTICLE; BLINDNESS; CANCER RISK; CARCINOGENESIS; DOSIMETRY; HORMONE DEPENDENCE; HUMAN; LIGHT; SUNLIGHT;

ANIMALS; CAUSALITY; CIRCADIAN RHYTHM; HUMANS; LIGHT; MELATONIN; NEOPLASMS, HORMONE-DEPENDENT; RISK FACTORS; TOPOGRAPHY, MEDICAL;

EID: 0036103156     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-28352     Document Type: Article

References (48)

1. Evidences associating pineal gland function with alterations in pigmentation
2. Melatonin. Intersociety symposium on new and neglected hormones
3. Light suppresses melatonin secretion in humans
4. Action spectra, dose-response relationships, and temporal aspects of light's effects on the pineal gland
5. Human melatonin regulation is not mediated by the three cone photopic visual system
6. Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle
7. Human melatonin suppression by light is intensity dependent
8. Signal transduction of light for melatonin regulation in humans
9. Melatonin supersensitivity to dim light in seasonal affective disorder
10. Does bright light suppress nocturnal melatonin secretion more in women than men?
11. Dose-response relationships for resetting of human circadian clock by light
12. Molecular neurobiology and genetics of circadian rhythms in mammals
13. Circadian programs in cyanobacteria: Adaptiveness and mechanism
14. Molecular cloning and characterization of the human CLOCK gene: Expression in the suprachiasmatic nuclei
15. Resetting of the circadian clock by a conditioned stimulus
16. Electric power use and breast cancer: A hypothesis
17. Melatonin in oncology
18. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat
19. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: Potenzial involvement of antiestrogenic mechanisms in vivo
20. Biologically based epidemiological studies of electric power and cancer
21. Melatonin: Receptor-mediated events that may affect breast and other steroid hormone-dependent cancers
22. Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer
23. Melatonin and tryptophan derivatives as free radical scavengers and antioxidants
24. Decisions about Environmental Health Risks: What are the Key Questions and How Does This Apply to Melatonin?
25. A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men
26. Electric power, pineal function, and the risk of breast cancer
27. Light in the built environment: Potenzial role of circadian disruption in endocrine disruption and breast cancer
28. Profound bilateral blindness and the incidence of breast cancer
29. Does winter darkness in the Artic protect against cancer? The melatonin hypothesis revisited
30. EMF dosimetry by geography - Beyond black box epidemiology. Re: "Invited commentary: Electromagnetic fields and cancer in railway workers"
31. Incidence of cancer among Finnish airline cabin attendants, 1967-92
32. Incidence of breast cancer in Norwegian female radio and telegraph operators
33. Increased breast cancer risk among women who work predominantly at night
34. Night-shift work, light-at-night, and the risk of breast cancer
35. Rotating night shifts and risk of breast cancer in the Nurses' Health Study
36. Light at night, shiftwork, and breast cancer risk
37. Reduced cancer incidence among the blind
38. Inverse association between breast cancer incidence and degree of visual impairment in Finland
39. Visual impairment and cancer: A population-based cohort study in Finland
40. Suppression of melatonin secretion in some blind patients by exposure to bright light
41. Suppression of melatonin by 2000-lux ill in humans with closed eyelids
42. No melatonin suppression by illumination of popliteal fossae or eyelids
43. New options to test the melatonin hypothesis
44. Sick individuals and sick populations
45. The "over-exposed" control group
46. Melatonin in humans